Literature DB >> 23173063

Alzheimer's disease: development of disease-modifying treatments is the challenge for our generation.

Craig W Lindsley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23173063      PMCID: PMC3503338          DOI: 10.1021/cn300190f

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


× No keyword cloud information.
  1 in total

Review 1.  Alzheimer's disease: clinical trials and drug development.

Authors:  Francesca Mangialasche; Alina Solomon; Bengt Winblad; Patrizia Mecocci; Miia Kivipelto
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

  1 in total
  5 in total

1.  ACS Chemical Neuroscience and neuroscience drug discovery as 2012 comes to a close.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-12-19       Impact factor: 4.418

2.  Histone H3 Ser57 and Thr58 phosphorylation in the brain of 5XFAD mice.

Authors:  Kyle W Anderson; Natalia Mast; Irina A Pikuleva; Illarion V Turko
Journal:  FEBS Open Bio       Date:  2015-06-25       Impact factor: 2.693

Review 3.  Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease.

Authors:  Barbara Troesch; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-12-10       Impact factor: 5.717

Review 4.  Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.

Authors:  Vivek Kumar Sharma; Vineet Mehta; Thakur Gurjeet Singh
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 5.  Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's Disease.

Authors:  Mario Caruana; Ruben Cauchi; Neville Vassallo
Journal:  Front Nutr       Date:  2016-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.